Template:Anabolic and androgenic activities of anabolic steroids
Jump to navigation
Jump to search
Steroid | Ref. / Std. |
Route | Anabolic activity by | Androgenic activity |
Dissociation index by | ||
---|---|---|---|---|---|---|---|
Nitr. ratio | Myotrophy | Nitr. ratio | Myotrophy | ||||
Androisoxazole | T | par. | 2.1 | ||||
MT | p.o. | 1.7 | |||||
MT | p.o. | 1.55 | 0.22 | 7 | |||
Androstanolone | TP | par. | 2.5 | 1.53 | 1.6 | ||
T | par. | 0.3 | |||||
MT | p.o. | 0.8 | |||||
MT | p.o. | 0.26 | 0.53 | 0.13 | |||
Bolasterone | MT | par. | 5.75a | 3 | 1.9 | ||
MT | p.o. | 4.2 | 1.3 | 3.2 | |||
MT | par. | 13.4 | 3.0 | 4.5 | |||
T | par. | 11.4 | 2.24–6.6 | 2–5 | |||
Clostebol acetate | TP | par. | 0.68 | 0.14 | 5 | ||
TP | par. | 1.26 | 0.483 | 3 | |||
T | par. | 0.10 | 0.03 | 3 | |||
Drostanolone | T | par. | 0.62–1.30 | 0.25–0.4 | 2.5–3.0 | ||
Ethyldienolone | MT | par. | 1.0 | 0.1 | 10 | ||
MT | p.o. | 1.5 | 0.3 | 5 | |||
Ethylestrenol | T | par. | 2.6 | ||||
MT | p.o. | 4 | |||||
MT | p.o. | 4.207 | 0.222 | 19 | |||
MT | p.o. | 1.7 | 0.21 | 8.1 | |||
MT | p.o. | 2.0 | 0.4 | 5 | |||
MT | par. | 0.4 | 0.17 | 2.3 | |||
Fluoxymesterone | MT | p.o. | 20 | 9.5 | 2 | ||
MT | p.o. | 28.2 | 4.5 | 6.3 | |||
MT | p.o. | 0.9 | |||||
MT | p.o. | 3.8 | 1.5 | 2.7 | |||
MT | p.o. | 0.72 | 0.46 | 1.5 | |||
MT | p.o. | 1.75 | 0.93 | 1.9 | |||
MT | p.o. | 5 | 9 | 0.55 | |||
T | par. | 1.6 | |||||
T | par. | 17.45 | 1.18–7.51 | –7.57 | 2.3–15 | ||
Mebolazine | T | par. | 0.27 | <0.06–0.12 | >2 | ||
MT | p.o. | 3.3 | 2.1 | 0.15 | 14 | 22 | |
Mestanolone | MT | p.o. | 0.8 | 1.0 | 0.8 | ||
Metandienone | T | par. | 0.5 | ||||
T | par. | 2.1 | 0.6 | 3.5 | |||
T | par. | 2.25 | |||||
T | par. | 0.89 | 0.45 | 1.97 | |||
MT | p.o. | 1.4 | |||||
MT | p.o. | 1.2 | 0.35 | 3.4 | |||
MT | par. | 1.9 | 0.64 | 3 | |||
TP | par. | 0.1 | 0.1 | 1.0 | |||
TP | par. | 6.0 | 0.8 | 7.5 | |||
Metenolone | MT | p.o. | 13 | ||||
T | par. | 16 | |||||
T | par. | 0.88 | 0.44–0.57 | 2 | |||
TP | par. | 0.30 | 0.01–0.02 | 15–30 | |||
Metenolone acetate | MT | p.o. | 0.86 | 0.12 | 7 | ||
Methandriol | MT | p.o. | 0.70 | 0.78 | 0.9 | ||
MT | p.o. | 0.8 | 0.68 | 1.8 | |||
MT | p.o. | 0.70 | 0.46 | 1.1 | 0.7 | ||
TP | par. | 0.067 | 0.025 | ||||
Methylclostebol | MT | par. | 0.85 | 0.1 | 8.5 | ||
MT | p.o. | 0.5 | 0.1–0.15 | 3–5 | |||
MT | p.o. | 0.65 | 0.32 | 0.12 | 5.4 | 2.7 | |
T | par. | 0.46 | 0.26–0.27 | 1.7–1.8 | |||
Methyldiazinol | MT | p.o. | 3.0 | 0.2 | 15 | ||
Methyltestosterone | T | p.o. | 1.14 | 0.94–1.03 | 1.1–1.2 | ||
Nandrolone | MT | p.o. | 0.73 | 0.074 | 9.9 | ||
T | par. | 3.3 | |||||
T | par. | 10 | |||||
T | p.o. | 5 | |||||
TP | par. | 16 | |||||
TP | par. | 10 | |||||
Nandrolone decanoate | TP | par. | 3.29–4.92 | 0.41–0.31 | 12.1–10.6 | ||
Nandrolone phenylpropionate | TP | par. | 2.2 | 0.14 | 16 | ||
TP | par. | 2.05 | 0.18 | 11.1 | |||
Norboletone | MT | p.o. | 16.3 | ||||
TP | par. | 3.4 | 0.15 | 20 | |||
Norclostebol acetate | TP | par. | 1.12 | 0.25 | 4.5 | ||
TP | par. | 0.57 | 0.04 | 14.2 | |||
Norethandrolone | TP | par. | 1.0 | 0.06 | 16 | ||
TP | par. | 0.8 | 0.12 | 6.6 | |||
TP | par. | 0.77 | 0.38 | 2 | |||
TP | par. | 3–4 | |||||
T | par. | 1.3 | |||||
MT | p.o. | 2 | 0.25–0.5 | 4–8 | |||
MT | p.o. | 0.75 | 0.22 | 3.4 | |||
MT | p.o. | 2 | |||||
MT | p.o. | 3.9 | 0.19 | 20 | |||
MT | p.o. | 6.7 | |||||
MT | p.o. | 1.028 | 0.335 | 3.1 | |||
Normethandrone | TP | par. | 1.0 | 0.06 | 16 | ||
T | par. | 4.5 | 0.37 | 12 | |||
T | p.o. | 14.2 | 6–1.92 | 2–7 | |||
T | p.o. | 0.60 | 0.25 | 2.4 | |||
MT | p.o. | 3.25 | 1.25 | 2.6 | |||
MT | p.o. | 4.6 | 1.1 | 4.2 | |||
MT | p.o. | 5.8 | 1.1 | 5.3 | |||
Oxabolone cipionate | TP | par. | 1.2–1.6 | 0.25–0.4 | 3–6 | ||
Oxandrolone | MT | p.o. | 6.3 | ||||
MT | par. | 3.22 | 0.24 | 13 | |||
Oxymesterone | MT | par. | 3.3 | 0.48 | 6.9 | ||
MT | par. | 3.3 | 0.5 | 6.6 | |||
MT | p.o. | 1.34 | 0.42–0.61 | 2.2–3.2 | |||
MT | p.o. | 4 | |||||
MT | p.o. | 1.8 | 0.36 | 5.0 | |||
T | par. | 4.3 | |||||
Oxymetholone | MT | par. | 1.46 | 0.31 | 4.7 | ||
MT | p.o. | 2.5 | |||||
MT | p.o. | 3.2 | 0.45 | 7.1 | |||
MT | p.o. | 1.75 | 0.2 | 8.75 | |||
MT | par. | 4.4 | 1.0 | 4.4 | |||
T | par. | 4.3 | |||||
T | par. | 2.3 | 0.64–1.0 | 2.3–3.6 | |||
T | par. | 2 | |||||
Stanozolol | MT | p.o. | 2 | 0.33 | 6 | ||
MT | p.o. | 2.2 | 0.33 | 7 | |||
MT | p.o. | 10 | 0.33 | 30 | |||
MT | p.o. | 3.2 | 0.3 | 10.6 | |||
MT | par. | 3.7 | 0.52 | 7.1 | |||
MT | p.o. | 2.5 | |||||
MT | p.o. | 0.4 | |||||
T | par. | 4.3 | |||||
T | par. | 7.5 | 2.5 | 3 | |||
TP | par. | 0.13 | 0.03 | 4 | |||
Testosterone | MT | p.o. | 0.6 | ||||
MT | par. | 2.0 | |||||
MT | p.o. | 0.36 | 0.28–0.50 | 0.7–1.3 | |||
MT | p.o. | 0.38 | 0.57 | 0.67 | |||
TP | par. | 0.17 | 0.63 | ||||
Tiomesterone | MT | p.o. | 4.65 | 0.61 | 7.5 | ||
Notes: All assays done with rodents, unless noted otherwise. Footnotes: a = Monkeys. Sources: [1][2] |
References
- ↑ Potts GO, Arnold A, Beyler AL (1976). "Dissociation of the Androgenic and Other Hormonal Activities from the Protein Anabolic Effects of Steroids". Anabolic-Androgenic Steroids. pp. 361–406. doi:10.1007/978-3-642-66353-6_11. ISBN 978-3-642-66355-0.
- ↑ Charles D. Kochakian (6 December 2012). Anabolic-Androgenic Steroids. Springer Science & Business Media. pp. 370–373, 380. ISBN 978-3-642-66353-6.